Heart failure & cardiomyopathies

Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus

J Am Coll CardiolPublished Case-crossover study

Main finding · HF hospitalizationResult — go to the resultOdds ratio 1.43 95% CI 1.27–1.63

Authors' conclusion

NSAIDs were widely used and were associated with an increased risk of first-time HF hospitalization in patients with T2DM. Patients with advanced age, elevated HbA1c levels, and new users of NSAID seemed more susceptible.

Study context

Population
Patients diagnosed with T2DM in Denmark 1998–2021, without previous heart failure (HF), rheumatic disease or NSAID use 120 days before diagnosis23,308 hospitalized with HF
Participants
331,189 patients
Comparison
Short-term NSAID use vs no use
Outcome
First-time HF hospitalization
Methodological detailsnationwide Danish registers, 28-day exposure windows
  • Nationwide Danish registers
  • 28-day exposure windows

Main finding

HF hospitalization

Odds ratio

1.43

95% CI 1.27–1.63

NSAID usevs No NSAID use
OR 1.43 (95% CI 1.27–1.63)

As reported in the abstract

Further findings

OutcomeOR (95% CI)
HF hospitalization by subgroupNSAID usevs No NSAID useAge ≥80 years1.78 (1.39–2.28)
HF hospitalization by subgroupNSAID usevs No NSAID useElevated HbA1c treated with 0 to 1 antidiabetic drug1.68 (1.00–2.88)
HF hospitalization by subgroupNSAID usevs No NSAID useWithout previous use of NSAIDs2.71 (1.78–4.23)

NSAID use within 1 year

Patients claiming ≥1 NSAID prescription
16%

Original publication

Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. Published 18 April 2023. doi:10.1016/j.jacc.2023.02.027

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.